학술논문
Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel SNX8-BRAF Gene Fusion.
Document Type
Article
Author
Source
Subject
*GENE fusion
*CHILD patients
*SARCOMA
*
*
Language
ISSN
2473-4284
Abstract
Case Report of a 5-year-old boy with recurrent spindle cell sarcoma with a novel SNX8-BRAF-fusion and activity with the investigational type II RAF-inhibitor tovorafenib. [ABSTRACT FROM AUTHOR]